Drug Transporter (DT) Information

General Information of DT
DT ID DTD0035
Gene Name SLC30A8
Protein Name Zinc transporter 8
Gene ID
169026
UniProt ID
Q8IWU4
TCDB ID
2.A.4.3.5
3D Structure

Crystal Structure

Crystallisation Method: EM

PDB ID: 6XPE

Corresponding Chain: A/B

Sequence Length: 50-369

Detail: Struture Info

Synonyms SLC30A8; Solute carrier family 30 member 8; ZNT8; ZnT-8
DT Family Cation Diffusion Facilitator (CDF) Family ;
Tissue Specificity In the endocrine pancreas, expressed ininsulin-producing beta cells. Expressed at relatively high levelsin subcutaneous fat tissue from lean persons; much lower levels invisceral fat, whether from lean or obese individuals, and insubcutaneous fat tissue from obese individuals. Expressed inperipheral blood mononuclear cells, including T-cells and B-cells,with great variation among individuals ranging from negative tostrongly positive.
Function This transporter may be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic beta-cells. Facilitates the accumulation of zinc from the cytoplasm into intracellular vesicles, being a zinc-efflux transporter.
Endogenous Substrate(s) Zn2+
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation
Mutation-induced Structural Variation (MSV)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Zinc salts
 Preclinical Drug Info Arthritis FA5Z [1]
References
1 Zinc transporter 8 (ZnT8) and cell function. Trends Endocrinol Metab. 2014 Aug;25(8):415-24.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.